SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,849 | +5.9% | 40 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $4,581 | -16.9% | 40 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $5,513 | -71.6% | 40 | -73.3% | 0.00% | -75.0% |
Q4 2022 | $19,437 | +14.3% | 150 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $17,000 | -26.1% | 150 | -51.9% | 0.00% | 0.0% |
Q2 2022 | $23,000 | -4.2% | 312 | -0.3% | 0.00% | 0.0% |
Q1 2022 | $24,000 | -91.0% | 313 | -89.5% | 0.00% | -90.2% |
Q4 2021 | $267,000 | -14.1% | 2,969 | -11.7% | 0.04% | -19.6% |
Q3 2021 | $311,000 | +10.7% | 3,362 | -7.0% | 0.05% | +10.9% |
Q2 2021 | $281,000 | -6.3% | 3,615 | -10.1% | 0.05% | -13.2% |
Q1 2021 | $300,000 | +11.1% | 4,022 | +153.9% | 0.05% | 0.0% |
Q4 2020 | $270,000 | +2.3% | 1,584 | -15.7% | 0.05% | -7.0% |
Q3 2020 | $264,000 | -77.6% | 1,878 | -74.4% | 0.06% | -79.1% |
Q2 2020 | $1,177,000 | +62.3% | 7,343 | -1.0% | 0.27% | +30.6% |
Q1 2020 | $725,000 | -24.8% | 7,416 | -0.7% | 0.21% | -8.3% |
Q4 2019 | $964,000 | +57.8% | 7,469 | -8.0% | 0.23% | +34.9% |
Q3 2019 | $611,000 | -55.7% | 8,116 | -10.6% | 0.17% | -54.2% |
Q2 2019 | $1,380,000 | +15.7% | 9,080 | -9.3% | 0.37% | +2.2% |
Q1 2019 | $1,193,000 | +11.9% | 10,006 | +2.5% | 0.36% | -0.8% |
Q4 2018 | $1,066,000 | -28.1% | 9,766 | +6.4% | 0.36% | -27.9% |
Q3 2018 | $1,483,000 | – | 9,181 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |